nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—OPRD1—epilepsy syndrome	0.355	0.566	CbGaD
Pentazocine—OPRM1—epilepsy syndrome	0.271	0.433	CbGaD
Pentazocine—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00456	0.127	CbGeAlD
Pentazocine—OPRD1—ganglion—epilepsy syndrome	0.00416	0.116	CbGeAlD
Pentazocine—OPRM1—ganglion—epilepsy syndrome	0.00284	0.0793	CbGeAlD
Pentazocine—EBP—Bortezomib—Lacosamide—epilepsy syndrome	0.00187	1	CbGdCrCtD
Pentazocine—OPRD1—forebrain—epilepsy syndrome	0.00175	0.0488	CbGeAlD
Pentazocine—OPRK1—forebrain—epilepsy syndrome	0.00168	0.0468	CbGeAlD
Pentazocine—OPRD1—telencephalon—epilepsy syndrome	0.00161	0.0449	CbGeAlD
Pentazocine—Levallorphan—OPRM1—epilepsy syndrome	0.00134	0.24	CrCbGaD
Pentazocine—OPRM1—brainstem—epilepsy syndrome	0.00123	0.0345	CbGeAlD
Pentazocine—OPRM1—forebrain—epilepsy syndrome	0.00119	0.0333	CbGeAlD
Pentazocine—OPRM1—telencephalon—epilepsy syndrome	0.0011	0.0306	CbGeAlD
Pentazocine—Butorphanol—OPRD1—epilepsy syndrome	0.00101	0.18	CrCbGaD
Pentazocine—OPRD1—head—epilepsy syndrome	0.001	0.0279	CbGeAlD
Pentazocine—OPRK1—head—epilepsy syndrome	0.000959	0.0268	CbGeAlD
Pentazocine—OPRD1—nervous system—epilepsy syndrome	0.000948	0.0265	CbGeAlD
Pentazocine—OPRD1—central nervous system—epilepsy syndrome	0.000913	0.0255	CbGeAlD
Pentazocine—OPRK1—nervous system—epilepsy syndrome	0.000909	0.0254	CbGeAlD
Pentazocine—Dezocine—OPRM1—epilepsy syndrome	0.000909	0.162	CrCbGaD
Pentazocine—SIGMAR1—telencephalon—epilepsy syndrome	0.000905	0.0253	CbGeAlD
Pentazocine—Levorphanol—OPRD1—epilepsy syndrome	0.000889	0.159	CrCbGaD
Pentazocine—OPRK1—central nervous system—epilepsy syndrome	0.000875	0.0244	CbGeAlD
Pentazocine—OPRK1—cerebellum—epilepsy syndrome	0.000856	0.0239	CbGeAlD
Pentazocine—OPRM1—midbrain—epilepsy syndrome	0.000787	0.022	CbGeAlD
Pentazocine—Butorphanol—OPRM1—epilepsy syndrome	0.000772	0.138	CrCbGaD
Pentazocine—OPRM1—spinal cord—epilepsy syndrome	0.000768	0.0214	CbGeAlD
Pentazocine—OPRD1—brain—epilepsy syndrome	0.000725	0.0202	CbGeAlD
Pentazocine—SIGMAR1—medulla oblongata—epilepsy syndrome	0.000711	0.0199	CbGeAlD
Pentazocine—OPRK1—brain—epilepsy syndrome	0.000695	0.0194	CbGeAlD
Pentazocine—OPRM1—head—epilepsy syndrome	0.000682	0.0191	CbGeAlD
Pentazocine—Levorphanol—OPRM1—epilepsy syndrome	0.00068	0.121	CrCbGaD
Pentazocine—SIGMAR1—midbrain—epilepsy syndrome	0.00065	0.0181	CbGeAlD
Pentazocine—OPRM1—nervous system—epilepsy syndrome	0.000647	0.0181	CbGeAlD
Pentazocine—SIGMAR1—spinal cord—epilepsy syndrome	0.000634	0.0177	CbGeAlD
Pentazocine—OPRM1—central nervous system—epilepsy syndrome	0.000623	0.0174	CbGeAlD
Pentazocine—SIGMAR1—cerebellum—epilepsy syndrome	0.000503	0.014	CbGeAlD
Pentazocine—OPRM1—brain—epilepsy syndrome	0.000494	0.0138	CbGeAlD
Pentazocine—SIGMAR1—brain—epilepsy syndrome	0.000408	0.0114	CbGeAlD
Pentazocine—Paraesthesia—Lamotrigine—epilepsy syndrome	0.000127	0.000554	CcSEcCtD
Pentazocine—Agitation—Valproic Acid—epilepsy syndrome	0.000127	0.000552	CcSEcCtD
Pentazocine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000127	0.000552	CcSEcCtD
Pentazocine—Asthenia—Fosphenytoin—epilepsy syndrome	0.000126	0.000551	CcSEcCtD
Pentazocine—Visual impairment—Gabapentin—epilepsy syndrome	0.000126	0.000551	CcSEcCtD
Pentazocine—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000126	0.000551	CcSEcCtD
Pentazocine—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000126	0.00055	CcSEcCtD
Pentazocine—Somnolence—Lamotrigine—epilepsy syndrome	0.000126	0.000548	CcSEcCtD
Pentazocine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000126	0.000548	CcSEcCtD
Pentazocine—Constipation—Carbamazepine—epilepsy syndrome	0.000125	0.000546	CcSEcCtD
Pentazocine—Dizziness—Propofol—epilepsy syndrome	0.000125	0.000545	CcSEcCtD
Pentazocine—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000125	0.000545	CcSEcCtD
Pentazocine—Pruritus—Fosphenytoin—epilepsy syndrome	0.000125	0.000544	CcSEcCtD
Pentazocine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000125	0.000543	CcSEcCtD
Pentazocine—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000124	0.000541	CcSEcCtD
Pentazocine—Vertigo—Valproic Acid—epilepsy syndrome	0.000124	0.00054	CcSEcCtD
Pentazocine—Asthenia—Vigabatrin—epilepsy syndrome	0.000123	0.000537	CcSEcCtD
Pentazocine—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000123	0.000536	CcSEcCtD
Pentazocine—Tinnitus—Gabapentin—epilepsy syndrome	0.000122	0.000533	CcSEcCtD
Pentazocine—Dizziness—Midazolam—epilepsy syndrome	0.000122	0.000533	CcSEcCtD
Pentazocine—Dysgeusia—Pregabalin—epilepsy syndrome	0.000122	0.000532	CcSEcCtD
Pentazocine—Pruritus—Vigabatrin—epilepsy syndrome	0.000122	0.00053	CcSEcCtD
Pentazocine—Asthenia—Diazepam—epilepsy syndrome	0.000121	0.000529	CcSEcCtD
Pentazocine—Constipation—Lamotrigine—epilepsy syndrome	0.000121	0.000528	CcSEcCtD
Pentazocine—Nausea—Acetazolamide—epilepsy syndrome	0.000121	0.000527	CcSEcCtD
Pentazocine—Dizziness—Levetiracetam—epilepsy syndrome	0.000121	0.000526	CcSEcCtD
Pentazocine—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000121	0.000526	CcSEcCtD
Pentazocine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000121	0.000526	CcSEcCtD
Pentazocine—Vomiting—Propofol—epilepsy syndrome	0.00012	0.000524	CcSEcCtD
Pentazocine—Muscle spasms—Pregabalin—epilepsy syndrome	0.00012	0.000522	CcSEcCtD
Pentazocine—Pruritus—Diazepam—epilepsy syndrome	0.00012	0.000522	CcSEcCtD
Pentazocine—Dermatitis—Propofol—epilepsy syndrome	0.000119	0.000519	CcSEcCtD
Pentazocine—Hypertension—Valproic Acid—epilepsy syndrome	0.000119	0.000519	CcSEcCtD
Pentazocine—Headache—Propofol—epilepsy syndrome	0.000118	0.000516	CcSEcCtD
Pentazocine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000118	0.000515	CcSEcCtD
Pentazocine—Chills—Gabapentin—epilepsy syndrome	0.000118	0.000513	CcSEcCtD
Pentazocine—Vomiting—Midazolam—epilepsy syndrome	0.000118	0.000513	CcSEcCtD
Pentazocine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000118	0.000512	CcSEcCtD
Pentazocine—Asthenia—Felbamate—epilepsy syndrome	0.000117	0.000512	CcSEcCtD
Pentazocine—Vision blurred—Pregabalin—epilepsy syndrome	0.000117	0.000512	CcSEcCtD
Pentazocine—Tremor—Pregabalin—epilepsy syndrome	0.000117	0.000509	CcSEcCtD
Pentazocine—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000117	0.000508	CcSEcCtD
Pentazocine—Dizziness—Fosphenytoin—epilepsy syndrome	0.000117	0.000508	CcSEcCtD
Pentazocine—Dermatitis—Midazolam—epilepsy syndrome	0.000116	0.000508	CcSEcCtD
Pentazocine—Vomiting—Levetiracetam—epilepsy syndrome	0.000116	0.000506	CcSEcCtD
Pentazocine—Headache—Midazolam—epilepsy syndrome	0.000116	0.000505	CcSEcCtD
Pentazocine—Pruritus—Felbamate—epilepsy syndrome	0.000116	0.000505	CcSEcCtD
Pentazocine—Diarrhoea—Diazepam—epilepsy syndrome	0.000116	0.000505	CcSEcCtD
Pentazocine—Dermatitis—Levetiracetam—epilepsy syndrome	0.000115	0.000502	CcSEcCtD
Pentazocine—Asthenia—Zonisamide—epilepsy syndrome	0.000115	0.000501	CcSEcCtD
Pentazocine—Agranulocytosis—Topiramate—epilepsy syndrome	0.000115	0.0005	CcSEcCtD
Pentazocine—Dry mouth—Valproic Acid—epilepsy syndrome	0.000115	0.0005	CcSEcCtD
Pentazocine—Agitation—Pregabalin—epilepsy syndrome	0.000114	0.000499	CcSEcCtD
Pentazocine—Headache—Levetiracetam—epilepsy syndrome	0.000114	0.000499	CcSEcCtD
Pentazocine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000114	0.000496	CcSEcCtD
Pentazocine—Dizziness—Vigabatrin—epilepsy syndrome	0.000114	0.000495	CcSEcCtD
Pentazocine—Confusional state—Valproic Acid—epilepsy syndrome	0.000113	0.000494	CcSEcCtD
Pentazocine—Pruritus—Zonisamide—epilepsy syndrome	0.000113	0.000494	CcSEcCtD
Pentazocine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000113	0.000493	CcSEcCtD
Pentazocine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000112	0.00049	CcSEcCtD
Pentazocine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000112	0.00049	CcSEcCtD
Pentazocine—Nausea—Propofol—epilepsy syndrome	0.000112	0.000489	CcSEcCtD
Pentazocine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000112	0.000489	CcSEcCtD
Pentazocine—Diarrhoea—Felbamate—epilepsy syndrome	0.000112	0.000488	CcSEcCtD
Pentazocine—Vertigo—Pregabalin—epilepsy syndrome	0.000112	0.000488	CcSEcCtD
Pentazocine—Dysgeusia—Gabapentin—epilepsy syndrome	0.000112	0.000488	CcSEcCtD
Pentazocine—Dizziness—Diazepam—epilepsy syndrome	0.000112	0.000488	CcSEcCtD
Pentazocine—Syncope—Pregabalin—epilepsy syndrome	0.000112	0.000487	CcSEcCtD
Pentazocine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000111	0.000484	CcSEcCtD
Pentazocine—Asthenia—Clonazepam—epilepsy syndrome	0.000111	0.000483	CcSEcCtD
Pentazocine—Headache—Fosphenytoin—epilepsy syndrome	0.00011	0.000481	CcSEcCtD
Pentazocine—Asthenia—Phenytoin—epilepsy syndrome	0.00011	0.00048	CcSEcCtD
Pentazocine—Nausea—Midazolam—epilepsy syndrome	0.00011	0.000479	CcSEcCtD
Pentazocine—Hallucination—Topiramate—epilepsy syndrome	0.00011	0.000479	CcSEcCtD
Pentazocine—Muscle spasms—Gabapentin—epilepsy syndrome	0.00011	0.000479	CcSEcCtD
Pentazocine—Tachycardia—Valproic Acid—epilepsy syndrome	0.00011	0.000478	CcSEcCtD
Pentazocine—Diarrhoea—Zonisamide—epilepsy syndrome	0.00011	0.000478	CcSEcCtD
Pentazocine—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000109	0.000477	CcSEcCtD
Pentazocine—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000109	0.000477	CcSEcCtD
Pentazocine—Pruritus—Clonazepam—epilepsy syndrome	0.000109	0.000476	CcSEcCtD
Pentazocine—Vomiting—Vigabatrin—epilepsy syndrome	0.000109	0.000476	CcSEcCtD
Pentazocine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000109	0.000474	CcSEcCtD
Pentazocine—Pruritus—Phenytoin—epilepsy syndrome	0.000109	0.000473	CcSEcCtD
Pentazocine—Nausea—Levetiracetam—epilepsy syndrome	0.000108	0.000473	CcSEcCtD
Pentazocine—Dizziness—Felbamate—epilepsy syndrome	0.000108	0.000472	CcSEcCtD
Pentazocine—Dermatitis—Vigabatrin—epilepsy syndrome	0.000108	0.000472	CcSEcCtD
Pentazocine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000108	0.000471	CcSEcCtD
Pentazocine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000108	0.00047	CcSEcCtD
Pentazocine—Vision blurred—Gabapentin—epilepsy syndrome	0.000108	0.000469	CcSEcCtD
Pentazocine—Headache—Vigabatrin—epilepsy syndrome	0.000108	0.000469	CcSEcCtD
Pentazocine—Hypertension—Pregabalin—epilepsy syndrome	0.000108	0.000469	CcSEcCtD
Pentazocine—Vomiting—Diazepam—epilepsy syndrome	0.000108	0.000469	CcSEcCtD
Pentazocine—Anorexia—Valproic Acid—epilepsy syndrome	0.000107	0.000467	CcSEcCtD
Pentazocine—Tremor—Gabapentin—epilepsy syndrome	0.000107	0.000467	CcSEcCtD
Pentazocine—Dermatitis—Diazepam—epilepsy syndrome	0.000107	0.000464	CcSEcCtD
Pentazocine—Visual impairment—Topiramate—epilepsy syndrome	0.000106	0.000464	CcSEcCtD
Pentazocine—Dizziness—Zonisamide—epilepsy syndrome	0.000106	0.000462	CcSEcCtD
Pentazocine—Headache—Diazepam—epilepsy syndrome	0.000106	0.000462	CcSEcCtD
Pentazocine—Diarrhoea—Clonazepam—epilepsy syndrome	0.000106	0.000461	CcSEcCtD
Pentazocine—Hypotension—Valproic Acid—epilepsy syndrome	0.000105	0.000458	CcSEcCtD
Pentazocine—Asthenia—Carbamazepine—epilepsy syndrome	0.000105	0.000458	CcSEcCtD
Pentazocine—Agitation—Gabapentin—epilepsy syndrome	0.000105	0.000458	CcSEcCtD
Pentazocine—Diarrhoea—Phenytoin—epilepsy syndrome	0.000105	0.000458	CcSEcCtD
Pentazocine—Nausea—Fosphenytoin—epilepsy syndrome	0.000105	0.000456	CcSEcCtD
Pentazocine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000104	0.000455	CcSEcCtD
Pentazocine—Erythema multiforme—Topiramate—epilepsy syndrome	0.000104	0.000455	CcSEcCtD
Pentazocine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000104	0.000455	CcSEcCtD
Pentazocine—Vomiting—Felbamate—epilepsy syndrome	0.000104	0.000454	CcSEcCtD
Pentazocine—Dry mouth—Pregabalin—epilepsy syndrome	0.000104	0.000452	CcSEcCtD
Pentazocine—Pruritus—Carbamazepine—epilepsy syndrome	0.000104	0.000452	CcSEcCtD
Pentazocine—Dermatitis—Felbamate—epilepsy syndrome	0.000103	0.00045	CcSEcCtD
Pentazocine—Tinnitus—Topiramate—epilepsy syndrome	0.000103	0.000449	CcSEcCtD
Pentazocine—Vertigo—Gabapentin—epilepsy syndrome	0.000103	0.000447	CcSEcCtD
Pentazocine—Headache—Felbamate—epilepsy syndrome	0.000103	0.000447	CcSEcCtD
Pentazocine—Confusional state—Pregabalin—epilepsy syndrome	0.000103	0.000447	CcSEcCtD
Pentazocine—Flushing—Topiramate—epilepsy syndrome	0.000102	0.000447	CcSEcCtD
Pentazocine—Syncope—Gabapentin—epilepsy syndrome	0.000102	0.000447	CcSEcCtD
Pentazocine—Dizziness—Clonazepam—epilepsy syndrome	0.000102	0.000445	CcSEcCtD
Pentazocine—Nausea—Vigabatrin—epilepsy syndrome	0.000102	0.000445	CcSEcCtD
Pentazocine—Vomiting—Zonisamide—epilepsy syndrome	0.000102	0.000444	CcSEcCtD
Pentazocine—Insomnia—Valproic Acid—epilepsy syndrome	0.000102	0.000443	CcSEcCtD
Pentazocine—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000102	0.000443	CcSEcCtD
Pentazocine—Asthenia—Lamotrigine—epilepsy syndrome	0.000102	0.000443	CcSEcCtD
Pentazocine—Dizziness—Phenytoin—epilepsy syndrome	0.000101	0.000442	CcSEcCtD
Pentazocine—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000101	0.00044	CcSEcCtD
Pentazocine—Dermatitis—Zonisamide—epilepsy syndrome	0.000101	0.00044	CcSEcCtD
Pentazocine—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000101	0.00044	CcSEcCtD
Pentazocine—Nausea—Diazepam—epilepsy syndrome	0.0001	0.000438	CcSEcCtD
Pentazocine—Loss of consciousness—Gabapentin—epilepsy syndrome	0.0001	0.000438	CcSEcCtD
Pentazocine—Headache—Zonisamide—epilepsy syndrome	0.0001	0.000438	CcSEcCtD
Pentazocine—Dyspnoea—Valproic Acid—epilepsy syndrome	0.0001	0.000437	CcSEcCtD
Pentazocine—Diarrhoea—Carbamazepine—epilepsy syndrome	0.0001	0.000437	CcSEcCtD
Pentazocine—Pruritus—Lamotrigine—epilepsy syndrome	0.0001	0.000436	CcSEcCtD
Pentazocine—Shock—Pregabalin—epilepsy syndrome	0.0001	0.000436	CcSEcCtD
Pentazocine—Somnolence—Valproic Acid—epilepsy syndrome	0.0001	0.000436	CcSEcCtD
Pentazocine—Tachycardia—Pregabalin—epilepsy syndrome	9.92e-05	0.000433	CcSEcCtD
Pentazocine—Chills—Topiramate—epilepsy syndrome	9.91e-05	0.000432	CcSEcCtD
Pentazocine—Hypertension—Gabapentin—epilepsy syndrome	9.86e-05	0.00043	CcSEcCtD
Pentazocine—Hyperhidrosis—Pregabalin—epilepsy syndrome	9.83e-05	0.000428	CcSEcCtD
Pentazocine—Vomiting—Clonazepam—epilepsy syndrome	9.82e-05	0.000428	CcSEcCtD
Pentazocine—Decreased appetite—Valproic Acid—epilepsy syndrome	9.78e-05	0.000426	CcSEcCtD
Pentazocine—Vomiting—Phenytoin—epilepsy syndrome	9.75e-05	0.000425	CcSEcCtD
Pentazocine—Dermatitis—Clonazepam—epilepsy syndrome	9.73e-05	0.000424	CcSEcCtD
Pentazocine—Nausea—Felbamate—epilepsy syndrome	9.72e-05	0.000424	CcSEcCtD
Pentazocine—Vomiting—Oxcarbazepine—epilepsy syndrome	9.7e-05	0.000423	CcSEcCtD
Pentazocine—Anorexia—Pregabalin—epilepsy syndrome	9.69e-05	0.000422	CcSEcCtD
Pentazocine—Dizziness—Carbamazepine—epilepsy syndrome	9.68e-05	0.000422	CcSEcCtD
Pentazocine—Diarrhoea—Lamotrigine—epilepsy syndrome	9.68e-05	0.000422	CcSEcCtD
Pentazocine—Headache—Clonazepam—epilepsy syndrome	9.67e-05	0.000422	CcSEcCtD
Pentazocine—Dermatitis—Phenytoin—epilepsy syndrome	9.66e-05	0.000421	CcSEcCtD
Pentazocine—Constipation—Valproic Acid—epilepsy syndrome	9.62e-05	0.000419	CcSEcCtD
Pentazocine—Dermatitis—Oxcarbazepine—epilepsy syndrome	9.61e-05	0.000419	CcSEcCtD
Pentazocine—Headache—Phenytoin—epilepsy syndrome	9.61e-05	0.000419	CcSEcCtD
Pentazocine—Headache—Oxcarbazepine—epilepsy syndrome	9.56e-05	0.000417	CcSEcCtD
Pentazocine—Nausea—Zonisamide—epilepsy syndrome	9.52e-05	0.000415	CcSEcCtD
Pentazocine—Dry mouth—Gabapentin—epilepsy syndrome	9.51e-05	0.000415	CcSEcCtD
Pentazocine—Hypotension—Pregabalin—epilepsy syndrome	9.5e-05	0.000414	CcSEcCtD
Pentazocine—Dysgeusia—Topiramate—epilepsy syndrome	9.41e-05	0.00041	CcSEcCtD
Pentazocine—Confusional state—Gabapentin—epilepsy syndrome	9.4e-05	0.00041	CcSEcCtD
Pentazocine—Dizziness—Lamotrigine—epilepsy syndrome	9.36e-05	0.000408	CcSEcCtD
Pentazocine—Anaphylactic shock—Gabapentin—epilepsy syndrome	9.32e-05	0.000406	CcSEcCtD
Pentazocine—Vomiting—Carbamazepine—epilepsy syndrome	9.31e-05	0.000406	CcSEcCtD
Pentazocine—Feeling abnormal—Valproic Acid—epilepsy syndrome	9.27e-05	0.000404	CcSEcCtD
Pentazocine—Muscle spasms—Topiramate—epilepsy syndrome	9.24e-05	0.000403	CcSEcCtD
Pentazocine—Dermatitis—Carbamazepine—epilepsy syndrome	9.22e-05	0.000402	CcSEcCtD
Pentazocine—Insomnia—Pregabalin—epilepsy syndrome	9.2e-05	0.000401	CcSEcCtD
Pentazocine—Nausea—Clonazepam—epilepsy syndrome	9.17e-05	0.0004	CcSEcCtD
Pentazocine—Headache—Carbamazepine—epilepsy syndrome	9.17e-05	0.0004	CcSEcCtD
Pentazocine—Shock—Gabapentin—epilepsy syndrome	9.17e-05	0.0004	CcSEcCtD
Pentazocine—Paraesthesia—Pregabalin—epilepsy syndrome	9.13e-05	0.000398	CcSEcCtD
Pentazocine—Nausea—Phenytoin—epilepsy syndrome	9.11e-05	0.000397	CcSEcCtD
Pentazocine—Tachycardia—Gabapentin—epilepsy syndrome	9.1e-05	0.000397	CcSEcCtD
Pentazocine—Dyspnoea—Pregabalin—epilepsy syndrome	9.06e-05	0.000395	CcSEcCtD
Pentazocine—Nausea—Oxcarbazepine—epilepsy syndrome	9.06e-05	0.000395	CcSEcCtD
Pentazocine—Vision blurred—Topiramate—epilepsy syndrome	9.06e-05	0.000395	CcSEcCtD
Pentazocine—Somnolence—Pregabalin—epilepsy syndrome	9.04e-05	0.000394	CcSEcCtD
Pentazocine—Hyperhidrosis—Gabapentin—epilepsy syndrome	9.01e-05	0.000393	CcSEcCtD
Pentazocine—Tremor—Topiramate—epilepsy syndrome	9e-05	0.000393	CcSEcCtD
Pentazocine—Vomiting—Lamotrigine—epilepsy syndrome	9e-05	0.000392	CcSEcCtD
Pentazocine—Dermatitis—Lamotrigine—epilepsy syndrome	8.91e-05	0.000389	CcSEcCtD
Pentazocine—Anorexia—Gabapentin—epilepsy syndrome	8.89e-05	0.000387	CcSEcCtD
Pentazocine—Headache—Lamotrigine—epilepsy syndrome	8.87e-05	0.000386	CcSEcCtD
Pentazocine—Decreased appetite—Pregabalin—epilepsy syndrome	8.84e-05	0.000385	CcSEcCtD
Pentazocine—Agitation—Topiramate—epilepsy syndrome	8.83e-05	0.000385	CcSEcCtD
Pentazocine—Hypotension—Gabapentin—epilepsy syndrome	8.71e-05	0.00038	CcSEcCtD
Pentazocine—Nausea—Carbamazepine—epilepsy syndrome	8.7e-05	0.000379	CcSEcCtD
Pentazocine—Constipation—Pregabalin—epilepsy syndrome	8.69e-05	0.000379	CcSEcCtD
Pentazocine—Vertigo—Topiramate—epilepsy syndrome	8.63e-05	0.000376	CcSEcCtD
Pentazocine—Syncope—Topiramate—epilepsy syndrome	8.62e-05	0.000376	CcSEcCtD
Pentazocine—Loss of consciousness—Topiramate—epilepsy syndrome	8.45e-05	0.000368	CcSEcCtD
Pentazocine—Insomnia—Gabapentin—epilepsy syndrome	8.43e-05	0.000368	CcSEcCtD
Pentazocine—Nausea—Lamotrigine—epilepsy syndrome	8.41e-05	0.000366	CcSEcCtD
Pentazocine—Feeling abnormal—Pregabalin—epilepsy syndrome	8.38e-05	0.000365	CcSEcCtD
Pentazocine—Paraesthesia—Gabapentin—epilepsy syndrome	8.37e-05	0.000365	CcSEcCtD
Pentazocine—Dyspnoea—Gabapentin—epilepsy syndrome	8.31e-05	0.000362	CcSEcCtD
Pentazocine—Hypertension—Topiramate—epilepsy syndrome	8.3e-05	0.000362	CcSEcCtD
Pentazocine—Somnolence—Gabapentin—epilepsy syndrome	8.29e-05	0.000361	CcSEcCtD
Pentazocine—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.29e-05	0.000361	CcSEcCtD
Pentazocine—Decreased appetite—Gabapentin—epilepsy syndrome	8.1e-05	0.000353	CcSEcCtD
Pentazocine—Asthenia—Valproic Acid—epilepsy syndrome	8.07e-05	0.000352	CcSEcCtD
Pentazocine—Dry mouth—Topiramate—epilepsy syndrome	8e-05	0.000349	CcSEcCtD
Pentazocine—Constipation—Gabapentin—epilepsy syndrome	7.97e-05	0.000348	CcSEcCtD
Pentazocine—Pruritus—Valproic Acid—epilepsy syndrome	7.96e-05	0.000347	CcSEcCtD
Pentazocine—Confusional state—Topiramate—epilepsy syndrome	7.91e-05	0.000345	CcSEcCtD
Pentazocine—Shock—Topiramate—epilepsy syndrome	7.72e-05	0.000336	CcSEcCtD
Pentazocine—Diarrhoea—Valproic Acid—epilepsy syndrome	7.69e-05	0.000335	CcSEcCtD
Pentazocine—Feeling abnormal—Gabapentin—epilepsy syndrome	7.68e-05	0.000335	CcSEcCtD
Pentazocine—Tachycardia—Topiramate—epilepsy syndrome	7.65e-05	0.000334	CcSEcCtD
Pentazocine—Hyperhidrosis—Topiramate—epilepsy syndrome	7.58e-05	0.000331	CcSEcCtD
Pentazocine—Hypersensitivity—Pregabalin—epilepsy syndrome	7.49e-05	0.000327	CcSEcCtD
Pentazocine—Anorexia—Topiramate—epilepsy syndrome	7.48e-05	0.000326	CcSEcCtD
Pentazocine—Dizziness—Valproic Acid—epilepsy syndrome	7.44e-05	0.000324	CcSEcCtD
Pentazocine—Hypotension—Topiramate—epilepsy syndrome	7.33e-05	0.000319	CcSEcCtD
Pentazocine—Asthenia—Pregabalin—epilepsy syndrome	7.29e-05	0.000318	CcSEcCtD
Pentazocine—Pruritus—Pregabalin—epilepsy syndrome	7.19e-05	0.000314	CcSEcCtD
Pentazocine—Vomiting—Valproic Acid—epilepsy syndrome	7.15e-05	0.000312	CcSEcCtD
Pentazocine—Insomnia—Topiramate—epilepsy syndrome	7.09e-05	0.000309	CcSEcCtD
Pentazocine—Dermatitis—Valproic Acid—epilepsy syndrome	7.08e-05	0.000309	CcSEcCtD
Pentazocine—Headache—Valproic Acid—epilepsy syndrome	7.04e-05	0.000307	CcSEcCtD
Pentazocine—Paraesthesia—Topiramate—epilepsy syndrome	7.04e-05	0.000307	CcSEcCtD
Pentazocine—Dyspnoea—Topiramate—epilepsy syndrome	6.99e-05	0.000305	CcSEcCtD
Pentazocine—Somnolence—Topiramate—epilepsy syndrome	6.97e-05	0.000304	CcSEcCtD
Pentazocine—Diarrhoea—Pregabalin—epilepsy syndrome	6.96e-05	0.000303	CcSEcCtD
Pentazocine—Hypersensitivity—Gabapentin—epilepsy syndrome	6.87e-05	0.000299	CcSEcCtD
Pentazocine—Decreased appetite—Topiramate—epilepsy syndrome	6.82e-05	0.000297	CcSEcCtD
Pentazocine—Dizziness—Pregabalin—epilepsy syndrome	6.72e-05	0.000293	CcSEcCtD
Pentazocine—Constipation—Topiramate—epilepsy syndrome	6.71e-05	0.000292	CcSEcCtD
Pentazocine—Asthenia—Gabapentin—epilepsy syndrome	6.69e-05	0.000292	CcSEcCtD
Pentazocine—Nausea—Valproic Acid—epilepsy syndrome	6.68e-05	0.000291	CcSEcCtD
Pentazocine—Pruritus—Gabapentin—epilepsy syndrome	6.6e-05	0.000288	CcSEcCtD
Pentazocine—Vomiting—Pregabalin—epilepsy syndrome	6.46e-05	0.000282	CcSEcCtD
Pentazocine—Feeling abnormal—Topiramate—epilepsy syndrome	6.46e-05	0.000282	CcSEcCtD
Pentazocine—Dermatitis—Pregabalin—epilepsy syndrome	6.4e-05	0.000279	CcSEcCtD
Pentazocine—Diarrhoea—Gabapentin—epilepsy syndrome	6.38e-05	0.000278	CcSEcCtD
Pentazocine—Headache—Pregabalin—epilepsy syndrome	6.37e-05	0.000278	CcSEcCtD
Pentazocine—Dizziness—Gabapentin—epilepsy syndrome	6.16e-05	0.000269	CcSEcCtD
Pentazocine—Nausea—Pregabalin—epilepsy syndrome	6.04e-05	0.000263	CcSEcCtD
Pentazocine—Vomiting—Gabapentin—epilepsy syndrome	5.93e-05	0.000258	CcSEcCtD
Pentazocine—Dermatitis—Gabapentin—epilepsy syndrome	5.87e-05	0.000256	CcSEcCtD
Pentazocine—Headache—Gabapentin—epilepsy syndrome	5.84e-05	0.000255	CcSEcCtD
Pentazocine—Hypersensitivity—Topiramate—epilepsy syndrome	5.78e-05	0.000252	CcSEcCtD
Pentazocine—Asthenia—Topiramate—epilepsy syndrome	5.63e-05	0.000245	CcSEcCtD
Pentazocine—Pruritus—Topiramate—epilepsy syndrome	5.55e-05	0.000242	CcSEcCtD
Pentazocine—Nausea—Gabapentin—epilepsy syndrome	5.54e-05	0.000241	CcSEcCtD
Pentazocine—Diarrhoea—Topiramate—epilepsy syndrome	5.37e-05	0.000234	CcSEcCtD
Pentazocine—Dizziness—Topiramate—epilepsy syndrome	5.19e-05	0.000226	CcSEcCtD
Pentazocine—Vomiting—Topiramate—epilepsy syndrome	4.99e-05	0.000217	CcSEcCtD
Pentazocine—Dermatitis—Topiramate—epilepsy syndrome	4.94e-05	0.000215	CcSEcCtD
Pentazocine—Headache—Topiramate—epilepsy syndrome	4.91e-05	0.000214	CcSEcCtD
Pentazocine—Nausea—Topiramate—epilepsy syndrome	4.66e-05	0.000203	CcSEcCtD
Pentazocine—OPRD1—Signaling Pathways—OPRM1—epilepsy syndrome	2.1e-05	0.000207	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	2.09e-05	0.000206	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AVP—epilepsy syndrome	2.09e-05	0.000206	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—POMC—epilepsy syndrome	2.07e-05	0.000204	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PTGS2—epilepsy syndrome	2.07e-05	0.000204	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.07e-05	0.000204	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.04e-05	0.000201	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CCL2—epilepsy syndrome	2.03e-05	0.0002	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.02e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—OPRD1—epilepsy syndrome	2.02e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNAO1—epilepsy syndrome	2.02e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—BDKRB1—epilepsy syndrome	2e-05	0.000197	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CHRM2—epilepsy syndrome	2e-05	0.000197	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CX3CL1—epilepsy syndrome	2e-05	0.000197	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	2e-05	0.000197	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.99e-05	0.000196	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.99e-05	0.000196	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR3—epilepsy syndrome	1.98e-05	0.000195	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.98e-05	0.000195	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CDC42—epilepsy syndrome	1.96e-05	0.000193	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CNR1—epilepsy syndrome	1.95e-05	0.000192	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GABBR1—epilepsy syndrome	1.95e-05	0.000192	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.94e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR7—epilepsy syndrome	1.94e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GRM1—epilepsy syndrome	1.94e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDYN—epilepsy syndrome	1.94e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CHRM1—epilepsy syndrome	1.94e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NPY—epilepsy syndrome	1.93e-05	0.00019	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.93e-05	0.00019	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR7—epilepsy syndrome	1.9e-05	0.000187	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AVP—epilepsy syndrome	1.89e-05	0.000187	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AGT—epilepsy syndrome	1.88e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HRH3—epilepsy syndrome	1.87e-05	0.000184	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HSPB1—epilepsy syndrome	1.86e-05	0.000184	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL3—epilepsy syndrome	1.86e-05	0.000184	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL2—epilepsy syndrome	1.86e-05	0.000184	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CRH—epilepsy syndrome	1.86e-05	0.000184	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—OXT—epilepsy syndrome	1.86e-05	0.000184	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.85e-05	0.000182	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—OPRM1—epilepsy syndrome	1.84e-05	0.000181	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCR5—epilepsy syndrome	1.84e-05	0.000181	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.82e-05	0.00018	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GAL—epilepsy syndrome	1.82e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GFAP—epilepsy syndrome	1.82e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT3—epilepsy syndrome	1.81e-05	0.000179	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP2—epilepsy syndrome	1.8e-05	0.000177	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CHRM3—epilepsy syndrome	1.8e-05	0.000177	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GRM5—epilepsy syndrome	1.8e-05	0.000177	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.8e-05	0.000177	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.77e-05	0.000175	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AVP—epilepsy syndrome	1.76e-05	0.000174	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR3—epilepsy syndrome	1.74e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.74e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.74e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTK2B—epilepsy syndrome	1.73e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TSC1—epilepsy syndrome	1.73e-05	0.000171	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.73e-05	0.00017	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AGT—epilepsy syndrome	1.71e-05	0.000168	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.69e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.69e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.69e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.69e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NPY—epilepsy syndrome	1.69e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NTRK2—epilepsy syndrome	1.68e-05	0.000166	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR2—epilepsy syndrome	1.68e-05	0.000166	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SST—epilepsy syndrome	1.68e-05	0.000166	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—DUSP6—epilepsy syndrome	1.67e-05	0.000165	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.65e-05	0.000163	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.65e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AGT—epilepsy syndrome	1.65e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.65e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PLAT—epilepsy syndrome	1.64e-05	0.000162	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL2—epilepsy syndrome	1.63e-05	0.000161	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL3—epilepsy syndrome	1.63e-05	0.000161	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CRH—epilepsy syndrome	1.63e-05	0.000161	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—OXT—epilepsy syndrome	1.63e-05	0.000161	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HSPB1—epilepsy syndrome	1.63e-05	0.000161	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCR5—epilepsy syndrome	1.61e-05	0.000159	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.6e-05	0.000158	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.58e-05	0.000156	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL12—epilepsy syndrome	1.58e-05	0.000156	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—POMC—epilepsy syndrome	1.58e-05	0.000156	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.58e-05	0.000156	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.58e-05	0.000155	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.58e-05	0.000155	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.57e-05	0.000155	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JUNB—epilepsy syndrome	1.55e-05	0.000153	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CNR1—epilepsy syndrome	1.55e-05	0.000153	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PLCB1—epilepsy syndrome	1.55e-05	0.000153	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.52e-05	0.00015	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TSC1—epilepsy syndrome	1.52e-05	0.00015	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTK2B—epilepsy syndrome	1.52e-05	0.00015	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR7—epilepsy syndrome	1.52e-05	0.000149	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.5e-05	0.000148	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AGT—epilepsy syndrome	1.5e-05	0.000147	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SST—epilepsy syndrome	1.48e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NTRK2—epilepsy syndrome	1.48e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR2—epilepsy syndrome	1.48e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HBEGF—epilepsy syndrome	1.47e-05	0.000145	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.47e-05	0.000145	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.47e-05	0.000145	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—DUSP6—epilepsy syndrome	1.46e-05	0.000144	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.45e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT3—epilepsy syndrome	1.44e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLAT—epilepsy syndrome	1.44e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—POMC—epilepsy syndrome	1.44e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NPY—epilepsy syndrome	1.43e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.43e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADAM10—epilepsy syndrome	1.41e-05	0.000139	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CCL2—epilepsy syndrome	1.4e-05	0.000138	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.39e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL12—epilepsy syndrome	1.39e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.39e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—POMC—epilepsy syndrome	1.39e-05	0.000137	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.38e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—OXT—epilepsy syndrome	1.38e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CRH—epilepsy syndrome	1.38e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.38e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.38e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.38e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.38e-05	0.000136	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JUNB—epilepsy syndrome	1.36e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CNR1—epilepsy syndrome	1.36e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.36e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PLCB1—epilepsy syndrome	1.36e-05	0.000134	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—S100B—epilepsy syndrome	1.33e-05	0.000132	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.33e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR7—epilepsy syndrome	1.33e-05	0.000131	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SOCS3—epilepsy syndrome	1.32e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDC42—epilepsy syndrome	1.32e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HBEGF—epilepsy syndrome	1.29e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.29e-05	0.000127	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.28e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.28e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AVP—epilepsy syndrome	1.28e-05	0.000126	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT3—epilepsy syndrome	1.27e-05	0.000125	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.26e-05	0.000125	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—POMC—epilepsy syndrome	1.26e-05	0.000124	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SST—epilepsy syndrome	1.25e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.25e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.25e-05	0.000123	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADAM10—epilepsy syndrome	1.24e-05	0.000122	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.24e-05	0.000122	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CCL2—epilepsy syndrome	1.23e-05	0.000121	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.22e-05	0.00012	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.22e-05	0.00012	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HES1—epilepsy syndrome	1.21e-05	0.000119	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FYN—epilepsy syndrome	1.17e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.17e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.17e-05	0.000116	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.17e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—S100B—epilepsy syndrome	1.17e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—H2AFX—epilepsy syndrome	1.17e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.17e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MEF2C—epilepsy syndrome	1.17e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.16e-05	0.000115	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SOCS3—epilepsy syndrome	1.16e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDC42—epilepsy syndrome	1.16e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	1.15e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	1.15e-05	0.000114	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	1.15e-05	0.000113	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.13e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	1.12e-05	0.000111	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AVP—epilepsy syndrome	1.12e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NGF—epilepsy syndrome	1.12e-05	0.00011	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.09e-05	0.000108	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR5—epilepsy syndrome	1.09e-05	0.000107	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.07e-05	0.000106	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.06e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR2A—epilepsy syndrome	1.06e-05	0.000105	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HES1—epilepsy syndrome	1.06e-05	0.000104	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.05e-05	0.000103	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—epilepsy syndrome	1.04e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.04e-05	0.000103	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FYN—epilepsy syndrome	1.03e-05	0.000101	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—H2AFX—epilepsy syndrome	1.03e-05	0.000101	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MEF2C—epilepsy syndrome	1.02e-05	0.000101	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TSC2—epilepsy syndrome	1.01e-05	9.94e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGT—epilepsy syndrome	1.01e-05	9.93e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	9.89e-06	9.75e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	9.89e-06	9.75e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	9.87e-06	9.73e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	9.79e-06	9.65e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	9.78e-06	9.64e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	9.77e-06	9.63e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	9.67e-06	9.53e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	9.52e-06	9.38e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	9.46e-06	9.32e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	9.31e-06	9.18e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	9.31e-06	9.18e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	9.27e-06	9.14e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	8.94e-06	8.82e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	8.85e-06	8.72e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	8.84e-06	8.71e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	8.7e-06	8.57e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	8.67e-06	8.54e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	8.66e-06	8.53e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	8.65e-06	8.53e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	8.48e-06	8.36e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	8.48e-06	8.36e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	8.36e-06	8.24e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	8.3e-06	8.18e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	8.27e-06	8.15e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	8.16e-06	8.05e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	8.13e-06	8.01e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	8.04e-06	7.93e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	7.87e-06	7.76e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	7.5e-06	7.39e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	7.48e-06	7.37e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	7.47e-06	7.36e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	7.44e-06	7.33e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	7.32e-06	7.21e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	7.28e-06	7.17e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	7.17e-06	7.07e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	6.96e-06	6.86e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	6.9e-06	6.8e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	6.87e-06	6.77e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	6.83e-06	6.73e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	6.58e-06	6.48e-05	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.34e-06	6.25e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	6.29e-06	6.2e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	6.28e-06	6.19e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	6.15e-06	6.06e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	6.11e-06	6.02e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	6.1e-06	6.01e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	5.99e-06	5.9e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	5.93e-06	5.85e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	5.76e-06	5.67e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	5.56e-06	5.48e-05	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.56e-06	5.48e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	5.51e-06	5.43e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	5.47e-06	5.39e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	5.35e-06	5.27e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	5.33e-06	5.25e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	5.2e-06	5.13e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	5.16e-06	5.09e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	5.06e-06	4.99e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	5.05e-06	4.97e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	4.8e-06	4.73e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.7e-06	4.63e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	4.67e-06	4.61e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	4.65e-06	4.59e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	4.52e-06	4.46e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	4.4e-06	4.33e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	4.27e-06	4.2e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	4.05e-06	4e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.95e-06	3.89e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	3.4e-06	3.35e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	2.98e-06	2.94e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	2.52e-06	2.48e-05	CbGpPWpGaD
